Patents by Inventor Michael D. Solga

Michael D. Solga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7858087
    Abstract: The present invention is directed to a composition and method for enhancing the complement-mediated cytotoxicity of therapeutic antibodies for their target cells (i.e. those cells displaying the target epitope). More particularly the present invention enhances the efficacy of such therapies by providing a supplemental source of complement.
    Type: Grant
    Filed: July 25, 2007
    Date of Patent: December 28, 2010
    Assignee: University of Virginia Patent Foundation
    Inventors: Ronald P. Taylor, Margaret A. Lindorfer, Michael D. Solga, Adam Kennedy
  • Patent number: 7255858
    Abstract: The present invention is directed to a composition and method for enhancing the complement-mediated cytotoxicity of therapeutic antibodies for their target cells (i.e. those cells displaying the target epitope). More particularly the present invention enhances the efficacy of such therapies by providing a supplemental source of complement.
    Type: Grant
    Filed: August 9, 2002
    Date of Patent: August 14, 2007
    Assignee: University of Virginia Patent Foundation
    Inventors: Ronald P. Taylor, Margaret A. Lindorfer, Michael D. Solga, Adam Kennedy
  • Publication number: 20040170633
    Abstract: The present invention is directed to a composition and method for enhancing the complement-mediated cytotoxicity of therapeutic antibodies for their target cells (i.e. those cells displaying the target epitope).
    Type: Application
    Filed: February 9, 2004
    Publication date: September 2, 2004
    Inventors: Ronald P Taylor, Margaret A. Lindorfer, Michael D. Solga, Adam A. Kennedy